University of California San Francisco

Jonathan Li
Jonathan Li, MD, MS

Resident (PGY-1)
General Surgery

[email protected]

Education

Institution Degree Dept or School End Date
University of California, San Francisco MAS Clinical and Epidemiologic Research 05/2024
University of California, San Francisco MD Medicine 05/2024
University of California, Berkeley BA Molecular and Cell Biology 05/2017

Awards & Honors

Award Conferred By Date
Long Term Dean's Prize Finalist UCSF 2024
Early Career Investigator Award in Clinical/Translational Science AASLD 2023
TL1 Blue Ribbon Award ACTS 2023
Burroughs Wellcome Fund Trainee Travel Award Burroughs Wellcome Fund 2023
UCSF Yearlong Research Fellowship UCSF 2022/2023

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 13
  1. A Computer Vision Algorithm to Predict Superior Mesenteric Artery Margin Status for Patients with Pancreatic Ductal Adenocarcinoma.
    Wang J, Ashraf Ganjouei A, Romero-Hernandez F, Foroutani L, Bahceci D, Deranteriassian A, Casey M, Li PY, Houshmand S, Behr S, Jamshidi N, Majumdar S, Donahue T, Kim GE, Wang ZJ, Thornblade LW, Adam M, Alseidi A| | PubMed
  2. Recent Advances in Liver Transplantation for Hepatocellular Carcinoma.
    Li PJ, Shah S, Mehta N| | PubMed
  3. Development and validation of a biomarker index for HCC treatment response.
    Liang J, Li PY, Norman J, Lauzon M, Yeo YH, Trivedi H, Ayoub WS, Kuo A, Friedman ML, Sankar K, Gong J, Osipov A, Hendifar A, Todo T, Kim I, Voidonikolas G, Brennan TV, Wisel SA, Steggarda J, Kosari K, Saouaf R, Nissen N, Yao F, Mehta N, Yang JD| | PubMed
  4. AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation.
    Norman JS, Li PJ, Kotwani P, Shui AM, Yao F, Mehta N| | PubMed
  5. AFP-L3 and DCP are superior to AFP in predicting waitlist dropout in HCC patients: Results of a prospective study.
    Mehta N, Kotwani P, Norman J, Shui A, Li PJ, Saxena V, Chan W, Yao FY| | PubMed
  6. Hospital-Based Donor Recruitment and Predonation Serologic Testing for COVID-19 Convalescent Plasma.
    Balcerek J, Trejo E, Levine K, Couey P, Kornberg ZV, Rogine C, Young C, Li PJ, Shy BR, Taylor JE, Bakhtary S, Friedlander T, Lynch KL, Bern C, Esensten JH| | PubMed
  7. Bioinformatic Approaches to Validation and Functional Analysis of 3D Lung Cancer Models.
    Li PJ, Roose JP, Jablons DM, Kratz JR| | PubMed
  8. Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies.
    Roth TL, Li PJ, Blaeschke F, Nies JF, Apathy R, Mowery C, Yu R, Nguyen MLT, Lee Y, Truong A, Hiatt J, Wu D, Nguyen DN, Goodman D, Bluestone JA, Ye CJ, Roybal K, Shifrut E, Marson A| | PubMed
  9. Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency.
    Nguyen DN, Roth TL, Li PJ, Chen PA, Apathy R, Mamedov MR, Vo LT, Tobin VR, Goodman D, Shifrut E, Bluestone JA, Puck JM, Szoka FC, Marson A| | PubMed
  10. Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.
    Shifrut E, Carnevale J, Tobin V, Roth TL, Woo JM, Bui CT, Li PJ, Diolaiti ME, Ashworth A, Marson A| | PubMed
13
View all 13 Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 13
  1. A Computer Vision Algorithm to Predict Superior Mesenteric Artery Margin Status for Patients with Pancreatic Ductal Adenocarcinoma.
    Wang J, Ashraf Ganjouei A, Romero-Hernandez F, Foroutani L, Bahceci D, Deranteriassian A, Casey M, Li PY, Houshmand S, Behr S, Jamshidi N, Majumdar S, Donahue T, Kim GE, Wang ZJ, Thornblade LW, Adam M, Alseidi A| | PubMed
  2. Recent Advances in Liver Transplantation for Hepatocellular Carcinoma.
    Li PJ, Shah S, Mehta N| | PubMed
  3. Development and validation of a biomarker index for HCC treatment response.
    Liang J, Li PY, Norman J, Lauzon M, Yeo YH, Trivedi H, Ayoub WS, Kuo A, Friedman ML, Sankar K, Gong J, Osipov A, Hendifar A, Todo T, Kim I, Voidonikolas G, Brennan TV, Wisel SA, Steggarda J, Kosari K, Saouaf R, Nissen N, Yao F, Mehta N, Yang JD| | PubMed
  4. AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation.
    Norman JS, Li PJ, Kotwani P, Shui AM, Yao F, Mehta N| | PubMed
  5. AFP-L3 and DCP are superior to AFP in predicting waitlist dropout in HCC patients: Results of a prospective study.
    Mehta N, Kotwani P, Norman J, Shui A, Li PJ, Saxena V, Chan W, Yao FY| | PubMed
  6. Hospital-Based Donor Recruitment and Predonation Serologic Testing for COVID-19 Convalescent Plasma.
    Balcerek J, Trejo E, Levine K, Couey P, Kornberg ZV, Rogine C, Young C, Li PJ, Shy BR, Taylor JE, Bakhtary S, Friedlander T, Lynch KL, Bern C, Esensten JH| | PubMed
  7. Bioinformatic Approaches to Validation and Functional Analysis of 3D Lung Cancer Models.
    Li PJ, Roose JP, Jablons DM, Kratz JR| | PubMed
  8. Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies.
    Roth TL, Li PJ, Blaeschke F, Nies JF, Apathy R, Mowery C, Yu R, Nguyen MLT, Lee Y, Truong A, Hiatt J, Wu D, Nguyen DN, Goodman D, Bluestone JA, Ye CJ, Roybal K, Shifrut E, Marson A| | PubMed
  9. Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency.
    Nguyen DN, Roth TL, Li PJ, Chen PA, Apathy R, Mamedov MR, Vo LT, Tobin VR, Goodman D, Shifrut E, Bluestone JA, Puck JM, Szoka FC, Marson A| | PubMed
  10. Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.
    Shifrut E, Carnevale J, Tobin V, Roth TL, Woo JM, Bui CT, Li PJ, Diolaiti ME, Ashworth A, Marson A| | PubMed
  11. Reprogramming human T cell function and specificity with non-viral genome targeting.
    Roth TL, Puig-Saus C, Yu R, Shifrut E, Carnevale J, Li PJ, Hiatt J, Saco J, Krystofinski P, Li H, Tobin V, Nguyen DN, Lee MR, Putnam AL, Ferris AL, Chen JW, Schickel JN, Pellerin L, Carmody D, Alkorta-Aranburu G, Del Gaudio D, Matsumoto H, Morell M, Mao Y, Cho M, Quadros RM, Gurumurthy CB, Smith B, Haugwitz M, Hughes SH, Weissman JS, Schumann K, Esensten JH, May AP, Ashworth A, Kupfer GM, Greeley SAW, Bacchetta R, Meffre E, Roncarolo MG, Romberg N, Herold KC, Ribas A, Leonetti MD, Marson A| | PubMed
  12. Tumor-derived CSF-1 induces the NKG2D ligand RAE-1δ on tumor-infiltrating macrophages.
    Thompson TW, Jackson BT, Li PJ, Wang J, Kim AB, Huang KTH, Zhang L, Raulet DH| | PubMed
  13. Endothelial cells express NKG2D ligands and desensitize antitumor NK responses.
    Thompson TW, Kim AB, Li PJ, Wang J, Jackson BT, Huang KTH, Zhang L, Raulet DH| | PubMed